US Patent Issued to Immunotech Biopharm, Pharos Vaccine, National Institutes for Food and Drug Control on Sept. 30 for "T-cell therapy method" (South Korean, Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,181, issued on Sept. 30, was assigned to Immunotech Biopharm Co. Ltd. (Beijing), Pharos Vaccine Inc. (Gyeonggi-do, South Korea) and National Institutes for Food and Drug Control (Beijing).

"T-cell therapy method" was invented by Yu Wang (Beijing), Hyunsoo Lee (Gyeonggi-do, South Korea), Namchul Jung (Gyeonggi-do, South Korea), Youchun Wang (Beijing), Lei Sun (Beijing), Qiang Liu (Beijing), Yonghua Zhang (Beijing) and Meng Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of biomedicine. Specifically, the present invention relates to an improved T-cell therapy. More specifically, the present inve...